These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 18458069

  • 41. IglE is an outer membrane-associated lipoprotein essential for intracellular survival and murine virulence of type A Francisella tularensis.
    Robertson GT, Child R, Ingle C, Celli J, Norgard MV.
    Infect Immun; 2013 Nov; 81(11):4026-40. PubMed ID: 23959721
    [Abstract] [Full Text] [Related]

  • 42. Effects of the putative transcriptional regulator IclR on Francisella tularensis pathogenesis.
    Mortensen BL, Fuller JR, Taft-Benz S, Kijek TM, Miller CN, Huang MT, Kawula TH.
    Infect Immun; 2010 Dec; 78(12):5022-32. PubMed ID: 20921148
    [Abstract] [Full Text] [Related]

  • 43. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K, Mann BJ, Qin A, Barry EM, Ernst RK, Vogel SN.
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [Abstract] [Full Text] [Related]

  • 44. Large direct repeats flank genomic rearrangements between a new clinical isolate of Francisella tularensis subsp. tularensis A1 and Schu S4.
    Nalbantoglu U, Sayood K, Dempsey MP, Iwen PC, Francesconi SC, Barabote RD, Xie G, Brettin TS, Hinrichs SH, Fey PD.
    PLoS One; 2010 Feb 03; 5(2):e9007. PubMed ID: 20140244
    [Abstract] [Full Text] [Related]

  • 45. Characterization of stable, constitutively expressed, chromosomal green and red fluorescent transcriptional fusions in the select agent bacterium, Francisella tularensis Schu S4 and the surrogate type B live vaccine strain (LVS).
    Su S, Saldanha R, Pemberton A, Bangar H, Kawamoto SA, Aronow B, Hassett DJ, Lamkin TJ.
    Appl Microbiol Biotechnol; 2013 Oct 03; 97(20):9029-41. PubMed ID: 23852642
    [Abstract] [Full Text] [Related]

  • 46. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W.
    Vaccine; 2012 May 21; 30(24):3634-45. PubMed ID: 22484348
    [Abstract] [Full Text] [Related]

  • 47. The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice.
    Bina XR, Lavine CL, Miller MA, Bina JE.
    FEMS Microbiol Lett; 2008 Feb 21; 279(2):226-33. PubMed ID: 18179581
    [Abstract] [Full Text] [Related]

  • 48. Francisella tularensis Schu S4 lipopolysaccharide core sugar and O-antigen mutants are attenuated in a mouse model of tularemia.
    Rasmussen JA, Post DM, Gibson BW, Lindemann SR, Apicella MA, Meyerholz DK, Jones BD.
    Infect Immun; 2014 Apr 21; 82(4):1523-39. PubMed ID: 24452684
    [Abstract] [Full Text] [Related]

  • 49. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A, Cerveny L, Spidlova P, Dankova V, Belcic D, Santic M, Stulik J.
    Microbes Infect; 2012 Feb 21; 14(2):177-87. PubMed ID: 21930232
    [Abstract] [Full Text] [Related]

  • 50. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
    Ryden P, Twine S, Shen H, Harris G, Chen W, Sjostedt A, Conlan W.
    Mol Immunol; 2013 May 21; 54(1):58-67. PubMed ID: 23201853
    [Abstract] [Full Text] [Related]

  • 51. Comparative proteome analysis of fractions enriched for membrane-associated proteins from Francisella tularensis subsp. tularensis and F. tularensis subsp. holarctica strains.
    Pavkova I, Reichelova M, Larsson P, Hubalek M, Vackova J, Forsberg A, Stulik J.
    J Proteome Res; 2006 Nov 21; 5(11):3125-34. PubMed ID: 17081064
    [Abstract] [Full Text] [Related]

  • 52. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
    Li J, Ryder C, Mandal M, Ahmed F, Azadi P, Snyder DS, Pechous RD, Zahrt T, Inzana TJ.
    Microbiology (Reading); 2007 Sep 21; 153(Pt 9):3141-3153. PubMed ID: 17768257
    [Abstract] [Full Text] [Related]

  • 53. Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages.
    Maier TM, Casey MS, Becker RH, Dorsey CW, Glass EM, Maltsev N, Zahrt TC, Frank DW.
    Infect Immun; 2007 Nov 21; 75(11):5376-89. PubMed ID: 17682043
    [Abstract] [Full Text] [Related]

  • 54. Acid phosphatases do not contribute to the pathogenesis of type A Francisella tularensis.
    Child R, Wehrly TD, Rockx-Brouwer D, Dorward DW, Celli J.
    Infect Immun; 2010 Jan 21; 78(1):59-67. PubMed ID: 19858304
    [Abstract] [Full Text] [Related]

  • 55. Components of the type six secretion system are substrates of Francisella tularensis Schu S4 DsbA-like FipB protein.
    Qin A, Zhang Y, Clark ME, Moore EA, Rabideau MM, Moreau GB, Mann BJ.
    Virulence; 2016 Nov 16; 7(8):882-894. PubMed ID: 27028889
    [Abstract] [Full Text] [Related]

  • 56. Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge.
    Tempel R, Lai XH, Crosa L, Kozlowicz B, Heffron F.
    Infect Immun; 2006 Sep 16; 74(9):5095-105. PubMed ID: 16926401
    [Abstract] [Full Text] [Related]

  • 57. Characterization of tetratricopeptide repeat-like proteins in Francisella tularensis and identification of a novel locus required for virulence.
    Dankova V, Balonova L, Straskova A, Spidlova P, Putzova D, Kijek T, Bozue J, Cote C, Mou S, Worsham P, Szotakova B, Cerveny L, Stulik J.
    Infect Immun; 2014 Dec 16; 82(12):5035-48. PubMed ID: 25245806
    [Abstract] [Full Text] [Related]

  • 58. Differential Substrate Usage and Metabolic Fluxes in Francisella tularensis Subspecies holarctica and Francisella novicida.
    Chen F, Rydzewski K, Kutzner E, Häuslein I, Schunder E, Wang X, Meighen-Berger K, Grunow R, Eisenreich W, Heuner K.
    Front Cell Infect Microbiol; 2017 Dec 16; 7():275. PubMed ID: 28680859
    [Abstract] [Full Text] [Related]

  • 59. The fslE homolog, FTL_0439 (fupA/B), mediates siderophore-dependent iron uptake in Francisella tularensis LVS.
    Sen B, Meeker A, Ramakrishnan G.
    Infect Immun; 2010 Oct 16; 78(10):4276-85. PubMed ID: 20696823
    [Abstract] [Full Text] [Related]

  • 60. Genome-wide identification of Francisella tularensis virulence determinants.
    Su J, Yang J, Zhao D, Kawula TH, Banas JA, Zhang JR.
    Infect Immun; 2007 Jun 16; 75(6):3089-101. PubMed ID: 17420240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.